Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 16 (MED16) is a protein located in the nucleus, where it forms part of the multi-subunit Mediator complex. This complex is a crucial transcriptional coactivator, connecting sequence-specific transcription factors to the RNA polymerase II machinery, thereby regulating the initiation of transcription for most protein-coding genes in eukaryotes. MED16 does not possess catalytic activity but contributes to the structural and functional integrity of the Mediator complex, affecting the expression of specific gene regulons in processes such as development, stress responses, and hormone signaling. In humans, mutations in MED16 are associated with certain intellectual disability syndromes.
Not applicable for direct targeting; MED16 conveys regulatory signals from transcription factors to the transcription preinitiation complex as a scaffold component
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 16 (MED16).